EEF2K and neoplasm: We previously reported that inhibition of eEF-2 kinase could render tumor cells more sensitive to AKT inhibitors [18], growth factor antagonists [21], ER stressors [17], metabolic stress [11] and glycolytic inhibitors [16], through modulating autophagy, a cellular process that can either promote cell survival or cell death.